The association of FGF-21 with the risk of newly diagnosed type-2 diabetes mellitus: a cross-sectional study in Southern China
Abstract Background This study investigated the relationship between fibroblast growth factor 21 (FGF-21) and newly diagnosed type-2 diabetes mellitus (T2DM). Methods In this cross-sectional study, FGF-21 and T2DM risk were analyzed using restricted cubic splines with univariate or multivariate logi...
Main Authors: | Lili You, Xiaosi Hong, Hongshi Wu, Diefei Liang, Feng Li, Dinghao Zheng, Xiuwei Zhang, Dan Liu, Qingyu Chen, Li Yan, Meng Ren, Wei Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-023-01426-y |
Similar Items
-
The role of FGF21 and its analogs on liver associated diseases
by: Kimia Falamarzi, et al.
Published: (2022-11-01) -
The potential function and clinical application of FGF21 in metabolic diseases
by: Zhiwei Chen, et al.
Published: (2022-12-01) -
The relationship between serum adipokine fibroblast growth factor‐21 and gestational diabetes mellitus
by: Xiaojiao Jia, et al.
Published: (2022-12-01) -
The Association Between FGF21 and Diabetic Erectile Dysfunction: Evidence from Clinical and Animal Studies
by: Song Yang, et al.
Published: (2022-06-01) -
Alteration of cognitive function in overweight and obese adolescents and its relationship with serum FGF21 levels
by: HAN Rui, et al.
Published: (2024-01-01)